APO RESEARCH · REPORT
Hyaluronic Acid-based Biomaterials
Hyaluronic acid-based biomaterials, is a carbohydrate, more specifically a mucopolysaccharide occurring naturally throughout the human body. It is found in the highest concentrations in fluids in the eyes and joints. It has been used in a wide range of orthopedic injections, ophthalmic solutions, viscoelastic injections for ophthalmic surgery, cosmetic fillers, surgical anti-adhesion products, skin care products and food supplements.
Product & engineering
Understand the product.
Hyaluronic acid-based biomaterials, is a carbohydrate, more specifically a mucopolysaccharide occurring naturally throughout the human body. It is found in the highest concentrations in fluids in the eyes and joints. It has been used in a wide range of orthopedic injections, ophthalmic solutions, viscoelastic injections for ophthalmic surgery, cosmetic fillers, surgical anti-adhesion products, skin care products and food supplements.
Common commercially available hyaluronic acid-based biomaterials are mainly hyaluronic acid. Hyaluronic acid (HA) is known as hyaluronan or hyaluronate. In this report, the volume of hyaluronic acid-based biomaterials is calculated by pure hyaluronic acid powder.
Selected research
Market Structure
Global Hyaluronic Acid-based Biomaterials Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Hyaluronic acid-based biomaterials, is a carbohydrate, more specifically a mucopolysaccharide occurring naturally throughout the human body. It is found in the highest concentrations in fluids in the eyes and joints. It has been used in a wide range of orthopedic injections, ophthalmic solutions, viscoelastic injections for ophthalmic surgery, cosmetic fillers, surgical anti-adhesion products, skin care products and food supplements.
Common commercially available hyaluronic acid-based biomaterials are mainly hyaluronic acid. Hyaluronic acid (HA) is known as hyaluronan or hyaluronate. In this report, the volume of hyaluronic acid-based biomaterials is calculated by pure hyaluronic acid powder.
The major manufacturers of Hyaluronic Acid-based Biomaterials are concentrated in Bloomage BioTechnology, Shandong Galaxy Bio-Tech, Kewpie, CPN, China Eastar and FocusChem Biotech. Bloomage BioTechnology is the world leader, holding 42% production market share.
Read the full market overview
In the consumption market, China is the largest consumption market. The consumption share of China is 27%.
The report provides an overview of the global Hyaluronic Acid-based Biomaterials market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Hyaluronic Acid-based Biomaterials and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Hyaluronic Acid-based Biomaterials sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Hyaluronic Acid-based Biomaterials market size, projected growth trends, production technologies, key applications, and end-use industries.
Hyaluronic Acid-based Biomaterials Segment by Company
Kewpie
CPN
Shiseido
Novozymes
Bloomage BioTechnology
Shandong Galaxy Bio-Tech
China Eastar
FocusChem Biotech
Shandong Topscience Biotech
QuFu GuangLong Biochem
Weifang Lide Bioengineering
Jiangsu Haihua Biotech
Qufu Liyang Biochem Industrial
Tongxiang Hengji biotechnology
Hyaluronic Acid-based Biomaterials Segment by Type
Cosmetic Grade
Food Grade
Pharmaceutical Grade
Hyaluronic Acid-based Biomaterials Segment by Application
Medical Hygiene
Plastic Surgery
Health Products
Cosmetic
Hyaluronic Acid-based Biomaterials Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hyaluronic Acid-based Biomaterials market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hyaluronic Acid-based Biomaterials and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hyaluronic Acid-based Biomaterials.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Hyaluronic Acid-based Biomaterials market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Hyaluronic Acid-based Biomaterials industry.
Chapter 3: Detailed analysis of Hyaluronic Acid-based Biomaterials market competition landscape. Including Hyaluronic Acid-based Biomaterials manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 7: Production/Production Value of Hyaluronic Acid-based Biomaterials by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 8: Consumption of Hyaluronic Acid-based Biomaterials in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Cosmetic Grade
- Food Grade
- Pharmaceutical Grade
Applications
- Medical Hygiene
- Plastic Surgery
- Health Products
- Cosmetic
Companies covered
- Kewpie
- CPN
- Shiseido
- Novozymes
- Bloomage BioTechnology
- Shandong Galaxy Bio-Tech
- China Eastar
- FocusChem Biotech
- Shandong Topscience Biotech
- QuFu GuangLong Biochem
- Weifang Lide Bioengineering
- Jiangsu Haihua Biotech
- Qufu Liyang Biochem Industrial
- Tongxiang Hengji biotechnology
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Hyaluronic Acid-based Biomaterials Production Value Estimates and Forecasts (2021-2032)
- 1.2.2 Global Hyaluronic Acid-based Biomaterials Production Capacity Estimates and Forecasts (2021-2032)
- 1.2.3 Global Hyaluronic Acid-based Biomaterials Production Estimates and Forecasts (2021-2032)
- 1.2.4 Global Hyaluronic Acid-based Biomaterials Market Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Global Hyaluronic Acid-based Biomaterials Market Dynamics
- 2.1 Hyaluronic Acid-based Biomaterials Industry Trends
- 2.2 Hyaluronic Acid-based Biomaterials Industry Drivers
- 2.3 Hyaluronic Acid-based Biomaterials Industry Opportunities and Challenges
- 2.4 Hyaluronic Acid-based Biomaterials Industry Restraints
3 Hyaluronic Acid-based Biomaterials Market by Manufacturers
- 3.1 Global Hyaluronic Acid-based Biomaterials Production Value by Manufacturers (2021-2026)
- 3.2 Global Hyaluronic Acid-based Biomaterials Production by Manufacturers (2021-2026)
- 3.3 Global Hyaluronic Acid-based Biomaterials Average Price by Manufacturers (2021-2026)
- 3.4 Global Hyaluronic Acid-based Biomaterials Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Hyaluronic Acid-based Biomaterials Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Hyaluronic Acid-based Biomaterials Manufacturers, Product Type & Application
- 3.7 Global Hyaluronic Acid-based Biomaterials Manufacturers Established Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Hyaluronic Acid-based Biomaterials Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Hyaluronic Acid-based Biomaterials Players Market Share by Production Value in 2025
- 3.8.3 2025 Hyaluronic Acid-based Biomaterials Tier 1, Tier 2, and Tier 3
4 Hyaluronic Acid-based Biomaterials Market by Type
- 4.1 Hyaluronic Acid-based Biomaterials Type Introduction
- 4.1.1 Cosmetic Grade
- 4.1.2 Food Grade
- 4.1.3 Pharmaceutical Grade
- 4.2 Global Hyaluronic Acid-based Biomaterials Production by Type
- 4.2.1 Global Hyaluronic Acid-based Biomaterials Production by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Hyaluronic Acid-based Biomaterials Production by Type (2021-2032)
- 4.2.3 Global Hyaluronic Acid-based Biomaterials Production Market Share by Type (2021-2032)
- 4.3 Global Hyaluronic Acid-based Biomaterials Production Value by Type
- 4.3.1 Global Hyaluronic Acid-based Biomaterials Production Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Hyaluronic Acid-based Biomaterials Production Value by Type (2021-2032)
- 4.3.3 Global Hyaluronic Acid-based Biomaterials Production Value Market Share by Type (2021-2032)
5 Hyaluronic Acid-based Biomaterials Market by Application
- 5.1 Hyaluronic Acid-based Biomaterials Application Introduction
- 5.1.1 Medical Hygiene
- 5.1.2 Plastic Surgery
- 5.1.3 Health Products
- 5.1.4 Cosmetic
- 5.2 Global Hyaluronic Acid-based Biomaterials Production by Application
- 5.2.1 Global Hyaluronic Acid-based Biomaterials Production by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Hyaluronic Acid-based Biomaterials Production by Application (2021-2032)
- 5.2.3 Global Hyaluronic Acid-based Biomaterials Production Market Share by Application (2021-2032)
- 5.3 Global Hyaluronic Acid-based Biomaterials Production Value by Application
- 5.3.1 Global Hyaluronic Acid-based Biomaterials Production Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Hyaluronic Acid-based Biomaterials Production Value by Application (2021-2032)
- 5.3.3 Global Hyaluronic Acid-based Biomaterials Production Value Market Share by Application (2021-2032)
6 Company Profiles
- 6.1 Kewpie
- 6.1.1 Kewpie Company Information
- 6.1.2 Kewpie Business Overview
- 6.1.3 Kewpie Hyaluronic Acid-based Biomaterials Production, Value and Gross Margin (2021-2026)
- 6.1.4 Kewpie Hyaluronic Acid-based Biomaterials Product Portfolio
- 6.1.5 Kewpie Recent Developments
- 6.2 CPN
- 6.2.1 CPN Company Information
- 6.2.2 CPN Business Overview
- 6.2.3 CPN Hyaluronic Acid-based Biomaterials Production, Value and Gross Margin (2021-2026)
- 6.2.4 CPN Hyaluronic Acid-based Biomaterials Product Portfolio
- 6.2.5 CPN Recent Developments
- 6.3 Shiseido
- 6.3.1 Shiseido Company Information
- 6.3.2 Shiseido Business Overview
- 6.3.3 Shiseido Hyaluronic Acid-based Biomaterials Production, Value and Gross Margin (2021-2026)
- 6.3.4 Shiseido Hyaluronic Acid-based Biomaterials Product Portfolio
- 6.3.5 Shiseido Recent Developments
- 6.4 Novozymes
- 6.4.1 Novozymes Company Information
- 6.4.2 Novozymes Business Overview
- 6.4.3 Novozymes Hyaluronic Acid-based Biomaterials Production, Value and Gross Margin (2021-2026)
- 6.4.4 Novozymes Hyaluronic Acid-based Biomaterials Product Portfolio
- 6.4.5 Novozymes Recent Developments
- 6.5 Bloomage BioTechnology
- 6.5.1 Bloomage BioTechnology Company Information
- 6.5.2 Bloomage BioTechnology Business Overview
- 6.5.3 Bloomage BioTechnology Hyaluronic Acid-based Biomaterials Production, Value and Gross Margin (2021-2026)
- 6.5.4 Bloomage BioTechnology Hyaluronic Acid-based Biomaterials Product Portfolio
- 6.5.5 Bloomage BioTechnology Recent Developments
- 6.6 Shandong Galaxy Bio-Tech
- 6.6.1 Shandong Galaxy Bio-Tech Company Information
- 6.6.2 Shandong Galaxy Bio-Tech Business Overview
- 6.6.3 Shandong Galaxy Bio-Tech Hyaluronic Acid-based Biomaterials Production, Value and Gross Margin (2021-2026)
- 6.6.4 Shandong Galaxy Bio-Tech Hyaluronic Acid-based Biomaterials Product Portfolio
- 6.6.5 Shandong Galaxy Bio-Tech Recent Developments
- 6.7 China Eastar
- 6.7.1 China Eastar Company Information
- 6.7.2 China Eastar Business Overview
- 6.7.3 China Eastar Hyaluronic Acid-based Biomaterials Production, Value and Gross Margin (2021-2026)
- 6.7.4 China Eastar Hyaluronic Acid-based Biomaterials Product Portfolio
- 6.7.5 China Eastar Recent Developments
- 6.8 FocusChem Biotech
- 6.8.1 FocusChem Biotech Company Information
- 6.8.2 FocusChem Biotech Business Overview
- 6.8.3 FocusChem Biotech Hyaluronic Acid-based Biomaterials Production, Value and Gross Margin (2021-2026)
- 6.8.4 FocusChem Biotech Hyaluronic Acid-based Biomaterials Product Portfolio
- 6.8.5 FocusChem Biotech Recent Developments
- 6.9 Shandong Topscience Biotech
- 6.9.1 Shandong Topscience Biotech Company Information
- 6.9.2 Shandong Topscience Biotech Business Overview
- 6.9.3 Shandong Topscience Biotech Hyaluronic Acid-based Biomaterials Production, Value and Gross Margin (2021-2026)
- 6.9.4 Shandong Topscience Biotech Hyaluronic Acid-based Biomaterials Product Portfolio
- 6.9.5 Shandong Topscience Biotech Recent Developments
- 6.10 QuFu GuangLong Biochem
- 6.10.1 QuFu GuangLong Biochem Company Information
- 6.10.2 QuFu GuangLong Biochem Business Overview
- 6.10.3 QuFu GuangLong Biochem Hyaluronic Acid-based Biomaterials Production, Value and Gross Margin (2021-2026)
- 6.10.4 QuFu GuangLong Biochem Hyaluronic Acid-based Biomaterials Product Portfolio
- 6.10.5 QuFu GuangLong Biochem Recent Developments
- 6.11 Weifang Lide Bioengineering
- 6.11.1 Weifang Lide Bioengineering Company Information
- 6.11.2 Weifang Lide Bioengineering Business Overview
- 6.11.3 Weifang Lide Bioengineering Hyaluronic Acid-based Biomaterials Production, Value and Gross Margin (2021-2026)
- 6.11.4 Weifang Lide Bioengineering Hyaluronic Acid-based Biomaterials Product Portfolio
- 6.11.5 Weifang Lide Bioengineering Recent Developments
- 6.12 Jiangsu Haihua Biotech
- 6.12.1 Jiangsu Haihua Biotech Company Information
- 6.12.2 Jiangsu Haihua Biotech Business Overview
- 6.12.3 Jiangsu Haihua Biotech Hyaluronic Acid-based Biomaterials Production, Value and Gross Margin (2021-2026)
- 6.12.4 Jiangsu Haihua Biotech Hyaluronic Acid-based Biomaterials Product Portfolio
- 6.12.5 Jiangsu Haihua Biotech Recent Developments
- 6.13 Qufu Liyang Biochem Industrial
- 6.13.1 Qufu Liyang Biochem Industrial Company Information
- 6.13.2 Qufu Liyang Biochem Industrial Business Overview
- 6.13.3 Qufu Liyang Biochem Industrial Hyaluronic Acid-based Biomaterials Production, Value and Gross Margin (2021-2026)
- 6.13.4 Qufu Liyang Biochem Industrial Hyaluronic Acid-based Biomaterials Product Portfolio
- 6.13.5 Qufu Liyang Biochem Industrial Recent Developments
- 6.14 Tongxiang Hengji biotechnology
- 6.14.1 Tongxiang Hengji biotechnology Company Information
- 6.14.2 Tongxiang Hengji biotechnology Business Overview
- 6.14.3 Tongxiang Hengji biotechnology Hyaluronic Acid-based Biomaterials Production, Value and Gross Margin (2021-2026)
- 6.14.4 Tongxiang Hengji biotechnology Hyaluronic Acid-based Biomaterials Product Portfolio
- 6.14.5 Tongxiang Hengji biotechnology Recent Developments
7 Global Hyaluronic Acid-based Biomaterials Production by Region
- 7.1 Global Hyaluronic Acid-based Biomaterials Production by Region: 2021 VS 2025 VS 2032
- 7.2 Global Hyaluronic Acid-based Biomaterials Production by Region (2021-2032)
- 7.2.1 Global Hyaluronic Acid-based Biomaterials Production by Region (2021-2026)
- 7.2.2 Global Hyaluronic Acid-based Biomaterials Production Forecast by Region (2027-2032)
- 7.3 Global Hyaluronic Acid-based Biomaterials Production by Region: 2021 VS 2025 VS 2032
- 7.4 Global Hyaluronic Acid-based Biomaterials Production Value by Region (2021-2032)
- 7.4.1 Global Hyaluronic Acid-based Biomaterials Production Value by Region (2021-2026)
- 7.4.2 Global Hyaluronic Acid-based Biomaterials Production Value by Region (2027-2032)
- 7.5 Global Hyaluronic Acid-based Biomaterials Market Price Analysis by Region (2021-2032)
- 7.6 Regional Production Value Trends (2021-2032)
- 7.6.1 North America Hyaluronic Acid-based Biomaterials Production Value (2021-2032)
- 7.6.2 Europe Hyaluronic Acid-based Biomaterials Production Value (2021-2032)
- 7.6.3 Asia-Pacific Hyaluronic Acid-based Biomaterials Production Value (2021-2032)
- 7.6.4 South America Hyaluronic Acid-based Biomaterials Production Value (2021-2032)
- 7.6.5 Middle East & Africa Hyaluronic Acid-based Biomaterials Production Value (2021-2032)
8 Global Hyaluronic Acid-based Biomaterials Consumption by Region
- 8.1 Global Hyaluronic Acid-based Biomaterials Consumption by Region: 2021 VS 2025 VS 2032
- 8.2 Global Hyaluronic Acid-based Biomaterials Consumption by Region (2021-2032)
- 8.2.1 Global Hyaluronic Acid-based Biomaterials Consumption by Region (2021-2026)
- 8.2.2 Global Hyaluronic Acid-based Biomaterials Consumption by Region (2027-2032)
- 8.3 North America
- 8.3.1 North America Hyaluronic Acid-based Biomaterials Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3.2 North America Hyaluronic Acid-based Biomaterials Consumption by Country (2021-2032)
- 8.3.3 U.S.
- 8.3.4 Canada
- 8.3.5 Mexico
- 8.4 Europe
- 8.4.1 Europe Hyaluronic Acid-based Biomaterials Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.4.2 Europe Hyaluronic Acid-based Biomaterials Consumption by Country (2021-2032)
- 8.4.3 Germany
- 8.4.4 France
- 8.4.5 U.K.
- 8.4.6 Italy
- 8.4.7 Netherlands
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Hyaluronic Acid-based Biomaterials Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.5.2 Asia Pacific Hyaluronic Acid-based Biomaterials Consumption by Country (2021-2032)
- 8.5.3 China
- 8.5.4 Japan
- 8.5.5 South Korea
- 8.5.6 Southeast Asia
- 8.5.7 India
- 8.5.8 Australia
- 8.6 South America
- 8.6.1 South America Hyaluronic Acid-based Biomaterials Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.6.2 South America Hyaluronic Acid-based Biomaterials Consumption by Country (2021-2032)
- 8.6.3 Brazil
- 8.6.4 Argentina
- 8.6.5 Chile
- 8.6.6 Colombia
- 8.7 Middle East & Africa
- 8.7.1 Middle East & Africa Hyaluronic Acid-based Biomaterials Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.7.2 Middle East & Africa Hyaluronic Acid-based Biomaterials Consumption by Country (2021-2032)
- 8.7.3 Egypt
- 8.7.4 South Africa
- 8.7.5 Israel
- 8.7.6 Türkiye
- 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
- 9.1 Hyaluronic Acid-based Biomaterials Value Chain Analysis
- 9.1.1 Hyaluronic Acid-based Biomaterials Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Hyaluronic Acid-based Biomaterials Production Mode & Process
- 9.2 Hyaluronic Acid-based Biomaterials Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Hyaluronic Acid-based Biomaterials Distributors
- 9.2.3 Hyaluronic Acid-based Biomaterials Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst